View this post on Instagram
An American biotech company says it created a coronavirus vaccine three hours after getting access to the virus' genetic sequence on Jan. 9, and now scientists are racing to get the vaccine on the market in record time. Inovio Pharmaceuticals is based in Pennsylvania, but scientists in its laboratory in San Diego made the discovery. "We have an algorithm which we designed, and we put the DNA sequence into our algorithm and came up with the vaccine in that short amount of time," Inovio's research and development director Dr. Trevor Smith told KVUE. Inovio's vaccine for COVID-19, as health officials have named the virus, could be ready as early as this summer. Inovio's stock jumped to $5.32 a share a few days after the company announced it was selected to work on a coronavirus vaccine. Shares are now at $3.34, back to where they were a month ago. The American company is partnering with Beijing Advaccine, a Chinese company, to work on the vaccine.
#USA: San Diego lab discovers COVID-19 vaccine in 3 hours— IndoPacific News (@IndoPac_Info) February 13, 2020
Inovio Pharmaceuticals created a vaccine that is going through pre-clinical trials. Via @fka_erin
If all goes as planned, the vaccine could be made available to the public by early this summerhttps://t.co/DhSGjdtseE